Formulation Study of a Poly(amino methacrylate) Film-Forming Solution for Transdermal Administration

Background/Objectives: The objective of this paper is to design a novel film-forming system (FFS) based on Eudragit<sup>®</sup> E PO (EuE) polymeric solutions, differing in volatile solvents (i.e., isopropanol and ethanol) and plasticizers (i.e., tributylcitrate, glycerine, triacetin and...

Full description

Saved in:
Bibliographic Details
Main Authors: Chiara G. M. Gennari, Antonella Casiraghi, Francesca Selmin, Francesco Cilurzo
Format: Article
Language:English
Published: MDPI AG 2025-01-01
Series:Pharmaceutics
Subjects:
Online Access:https://www.mdpi.com/1999-4923/17/1/88
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832587718811451392
author Chiara G. M. Gennari
Antonella Casiraghi
Francesca Selmin
Francesco Cilurzo
author_facet Chiara G. M. Gennari
Antonella Casiraghi
Francesca Selmin
Francesco Cilurzo
author_sort Chiara G. M. Gennari
collection DOAJ
description Background/Objectives: The objective of this paper is to design a novel film-forming system (FFS) based on Eudragit<sup>®</sup> E PO (EuE) polymeric solutions, differing in volatile solvents (i.e., isopropanol and ethanol) and plasticizers (i.e., tributylcitrate, glycerine, triacetin and PEG 400). Methods: The physicochemical and mechanical properties of the FFS and dried films were evaluated in terms of formation time, stickiness, T<sub>g</sub>, tensile strength, break elongation and Young’s modulus. The in vitro skin permeation studies were conducted on formulations containing caffeine and testosterone. Results: The FFS, consisting of EuE and PEG400 in isopropyl alcohol and ethanol (80:20, <i>v</i>/<i>v</i>), exhibited rapid film formation within about 5 min and the dried film allowed a high skin permeability compared to other formulations due to the ability to increase the thermodynamic activity of both drugs. When triiodothyronine (T3) was loaded as a model of a very low soluble drug, tocopherol polyethylene glycol succinate (TPGS) was added as a co-solvent and it allowed for the improvement of T3 retention in the skin. Conclusions: Among the formulative variables, the nature and the amount of plasticizer represent the most critical variables to obtain an EuE-based film with satisfying physical and biopharmaceutical properties.
format Article
id doaj-art-7e7629643b6b4b42b88e349b54cc9f05
institution Kabale University
issn 1999-4923
language English
publishDate 2025-01-01
publisher MDPI AG
record_format Article
series Pharmaceutics
spelling doaj-art-7e7629643b6b4b42b88e349b54cc9f052025-01-24T13:45:54ZengMDPI AGPharmaceutics1999-49232025-01-011718810.3390/pharmaceutics17010088Formulation Study of a Poly(amino methacrylate) Film-Forming Solution for Transdermal AdministrationChiara G. M. Gennari0Antonella Casiraghi1Francesca Selmin2Francesco Cilurzo3Department of Pharmaceutical Sciences, Università degli Studi di Milano, via G: Colombo, 71, 20133 Milano, ItalyDepartment of Pharmaceutical Sciences, Università degli Studi di Milano, via G: Colombo, 71, 20133 Milano, ItalyDepartment of Pharmaceutical Sciences, Università degli Studi di Milano, via G: Colombo, 71, 20133 Milano, ItalyDepartment of Pharmaceutical Sciences, Università degli Studi di Milano, via G: Colombo, 71, 20133 Milano, ItalyBackground/Objectives: The objective of this paper is to design a novel film-forming system (FFS) based on Eudragit<sup>®</sup> E PO (EuE) polymeric solutions, differing in volatile solvents (i.e., isopropanol and ethanol) and plasticizers (i.e., tributylcitrate, glycerine, triacetin and PEG 400). Methods: The physicochemical and mechanical properties of the FFS and dried films were evaluated in terms of formation time, stickiness, T<sub>g</sub>, tensile strength, break elongation and Young’s modulus. The in vitro skin permeation studies were conducted on formulations containing caffeine and testosterone. Results: The FFS, consisting of EuE and PEG400 in isopropyl alcohol and ethanol (80:20, <i>v</i>/<i>v</i>), exhibited rapid film formation within about 5 min and the dried film allowed a high skin permeability compared to other formulations due to the ability to increase the thermodynamic activity of both drugs. When triiodothyronine (T3) was loaded as a model of a very low soluble drug, tocopherol polyethylene glycol succinate (TPGS) was added as a co-solvent and it allowed for the improvement of T3 retention in the skin. Conclusions: Among the formulative variables, the nature and the amount of plasticizer represent the most critical variables to obtain an EuE-based film with satisfying physical and biopharmaceutical properties.https://www.mdpi.com/1999-4923/17/1/88drug delivery systemEudragit<sup>®</sup> Efilm-forming solutionplasticizerskin permeabilitysupersaturation
spellingShingle Chiara G. M. Gennari
Antonella Casiraghi
Francesca Selmin
Francesco Cilurzo
Formulation Study of a Poly(amino methacrylate) Film-Forming Solution for Transdermal Administration
Pharmaceutics
drug delivery system
Eudragit<sup>®</sup> E
film-forming solution
plasticizer
skin permeability
supersaturation
title Formulation Study of a Poly(amino methacrylate) Film-Forming Solution for Transdermal Administration
title_full Formulation Study of a Poly(amino methacrylate) Film-Forming Solution for Transdermal Administration
title_fullStr Formulation Study of a Poly(amino methacrylate) Film-Forming Solution for Transdermal Administration
title_full_unstemmed Formulation Study of a Poly(amino methacrylate) Film-Forming Solution for Transdermal Administration
title_short Formulation Study of a Poly(amino methacrylate) Film-Forming Solution for Transdermal Administration
title_sort formulation study of a poly amino methacrylate film forming solution for transdermal administration
topic drug delivery system
Eudragit<sup>®</sup> E
film-forming solution
plasticizer
skin permeability
supersaturation
url https://www.mdpi.com/1999-4923/17/1/88
work_keys_str_mv AT chiaragmgennari formulationstudyofapolyaminomethacrylatefilmformingsolutionfortransdermaladministration
AT antonellacasiraghi formulationstudyofapolyaminomethacrylatefilmformingsolutionfortransdermaladministration
AT francescaselmin formulationstudyofapolyaminomethacrylatefilmformingsolutionfortransdermaladministration
AT francescocilurzo formulationstudyofapolyaminomethacrylatefilmformingsolutionfortransdermaladministration